Expert Review of Pharmacoeconomics & Outcomes Research
Impact Factor Trend (2018–2026)
Clarivate IF trend for Expert Review of Pharmacoeconomics & Outcomes Research
SCImago Journal Rank citation prestige weighting
69 papers with at least that number of citations each
Aims & Scope
Expert Review of Pharmacoeconomics & Outcomes Research (ISSN 1473-7167) provides expert reviews on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research. All articles are subject to rigorous peer-review. The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections: Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results Article Highlights – an executive summary of the author’s most critical points.
Special Issues
Calls for PapersNo active Calls for Papers found for this journal.
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
HEALTH CARE SCIENCES & SERVICES
HEALTH POLICY & SERVICES
PHARMACOLOGY & PHARMACY
HEALTH CARE SCIENCES & SERVICES
HEALTH POLICY & SERVICES
PHARMACOLOGY & PHARMACY
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Journal Metrics & Citation Visualizations
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Academic Intelligence Overview & Context
ImpaQ AnalysisExpert Review of Pharmacoeconomics & Outcomes Research (acronym: erp, abbr: EXPERT REV PHARM OUT, ISSN: 1473-7167) is a peer-reviewed international scholarly journal in the field of HEALTH CARE SCIENCES & SERVICES, published by Taylor and Francis Ltd. in England. The periodical holds a Journal Impact Factor (JIF) of 2.20, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.511 (Q3), an H-index of 69.
The journal enforces rigorous peer evaluation with an annual output of approximately 118 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,014 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics